Page 39 - Cellular Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study results directly impact clinical practice with robust evidence supporting current guidelines for SARS-CoV-2 vaccination starting three months...

Samer A. Srour, MB ChB, MS, discusses the mechanism of action of ALLO-316, which is being investigated for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma, and details safety findings from the phase 1 TRAVERSE study evaluating ALLO-316 in this patient population.

Various treatment options for patients with relapsed/refractory MM are discussed.

Patients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vaccines for protection against SARS-CoV-2 three months post-transplant, according to a large, prospective, observational study led collaboratively by the Center for International Blood and Marrow Transplant Research, the Blood & Marrow Transplant Clinical Trials Network and Fred Hutchinson Cancer Center. The research, involving 22 cancer centers and research institutions in the United States and focusing on mRNA-based vaccines, published in The Lancet journal eCli...

Prenatal screening is of utmost importance to prevent thalassemia, a blood disorder, said doctors here calling on the need to increase screening. Here's everything about prenatal care to prevent this major blood disorder.